{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T19:12:31Z","timestamp":1793905951084,"version":"4.8.0"},"reference-count":60,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100010751","name":"Indian Rheumatology Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010751","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["3\/1\/1(20)\/2022-NCD-I"],"award-info":[{"award-number":["3\/1\/1(20)\/2022-NCD-I"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["5\/4\/1-2\/2019-NCD-II"],"award-info":[{"award-number":["5\/4\/1-2\/2019-NCD-II"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Rheumatology"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.berh.2023.101826","type":"journal-article","created":{"date-parts":[[2023,5,26]],"date-time":"2023-05-26T01:03:28Z","timestamp":1685063008000},"page":"101826","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"title":["Management of Takayasu arteritis"],"prefix":"10.1016","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5035-7396","authenticated-orcid":false,"given":"Durga Prasanna","family":"Misra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kritika","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Upendra","family":"Rathore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengappa G.","family":"Kavadichanda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manish","family":"Ora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neeraj","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikas","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl 1","key":"10.1016\/j.berh.2023.101826_bib1","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/1756-185X.13285","article-title":"Recent advances in the management of Takayasu arteritis","volume":"22","author":"Misra","year":"2019","journal-title":"Int J Rheum Dis"},{"key":"10.1016\/j.berh.2023.101826_bib2","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1002\/art.42324","article-title":"American College of Rheumatology\/EULAR classification criteria for Takayasu arteritis","volume":"74","author":"Grayson","year":"2022","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.berh.2023.101826_bib3","doi-asserted-by":"crossref","DOI":"10.1093\/rheumatology\/kead161","article-title":"Validation of the 2022 American College of Rheumatology\/EULAR classification criteria for Takayasu arteritis","author":"Tomelleri","year":"2023","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.berh.2023.101826_bib4","doi-asserted-by":"crossref","first-page":"3601","DOI":"10.1007\/s10067-022-06318-5","article-title":"Presentation and clinical course of pediatric-onset versus adult-onset Takayasu arteritis-a systematic review and meta-analysis","volume":"41","author":"Misra","year":"2022","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.berh.2023.101826_bib5","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.semarthrit.2020.04.012","article-title":"Patterns of clinical presentation in Takayasu's arteritis","volume":"50","author":"Quinn","year":"2020","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.berh.2023.101826_bib6","first-page":"1904","article-title":"Comparison of presentation and prognosis of Takayasu arteritis with or without stroke or transient ischemic attack-A retrospective cohort study","volume":"12","author":"Misra","year":"2022","journal-title":"Life (Basel)"},{"key":"10.1016\/j.berh.2023.101826_bib7","doi-asserted-by":"crossref","first-page":"3102","DOI":"10.3390\/diagnostics12123102","article-title":"Impact of geographic location on diagnosis and initial management of Takayasu arteritis: a tale of two cohorts from Italy and India","volume":"12","author":"Misra","year":"2022","journal-title":"Diagnostics(Basel)"},{"key":"10.1016\/j.berh.2023.101826_bib8","doi-asserted-by":"crossref","first-page":"919","DOI":"10.7326\/0003-4819-120-11-199406010-00004","article-title":"Takayasu arteritis","volume":"120","author":"Kerr","year":"1994","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.berh.2023.101826_bib9","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1093\/rheumatology\/keq171","article-title":"Assessment of disease activity and progression in Takayasu's arteritis with Disease Extent Index-Takayasu","volume":"49","author":"Aydin","year":"2010","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.berh.2023.101826_bib10","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1093\/rheumatology\/ket128","article-title":"Development and initial validation of the Indian Takayasu clinical activity score (ITAS2010)","volume":"52","author":"Misra","year":"2013","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.berh.2023.101826_bib11","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.3899\/jrheum.140817","article-title":"Assessment of patients with Takayasu arteritis in routine practice with Indian Takayasu clinical activity score","volume":"42","author":"Alibaz-Oner","year":"2015","journal-title":"J\u00a0Rheumatol"},{"issue":"Suppl 124","key":"10.1016\/j.berh.2023.101826_bib12","first-page":"55","article-title":"Imaging is the major determinant in the assessment of disease activity in Takayasu's arteritis","volume":"38","author":"Kenar","year":"2020","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.berh.2023.101826_bib13","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1002\/art.40037","article-title":"A\u00a0randomized, double-blind trial of abatacept (CTLA-4Ig) for the treatment of Takayasu arteritis","volume":"69","author":"Langford","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.berh.2023.101826_bib14","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1136\/annrheumdis-2019-215672","article-title":"Update of the EULAR recommendations for the management of large vessel vasculitis","volume":"79","author":"Hellmich","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2023.101826_bib15","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.3390\/diagnostics12102565","article-title":"Outcome measures and biomarkers for disease assessment in Takayasu arteritis","volume":"12","author":"Misra","year":"2022","journal-title":"Diagnostics(Basel)"},{"key":"10.1016\/j.berh.2023.101826_bib16","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.3899\/jrheum.131117","article-title":"Childhood-onset Takayasu arteritis -- experience from a tertiary care center in South India","volume":"41","author":"Goel","year":"2014","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.berh.2023.101826_bib17","volume":"69","author":"Sreih","year":"2017"},{"key":"10.1016\/j.berh.2023.101826_bib18","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1007\/s40744-021-00355-3","article-title":"Patient-reported outcome measures in Takayasu arteritis: a systematic review and meta-analysis","volume":"8","author":"Misra","year":"2021","journal-title":"Rheumatol Ther"},{"issue":"Suppl 111","key":"10.1016\/j.berh.2023.101826_bib19","first-page":"51","article-title":"Health-related outcomes of importance to patients with Takayasu's arteritis","volume":"36","author":"Sreih","year":"2018","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.berh.2023.101826_bib20","doi-asserted-by":"crossref","first-page":"oeab019","DOI":"10.1093\/ehjopen\/oeab019","article-title":"Pericoronary and periaortic adipose tissue density are associated with inflammatory disease activity in Takayasu arteritis and atherosclerosis","volume":"1","author":"Wall","year":"2021","journal-title":"Eur Heart J Open"},{"key":"10.1016\/j.berh.2023.101826_bib21","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1136\/annrheumdis-2019-216213","article-title":"'Slope sign': a feature of large vessel vasculitis?","volume":"78","author":"Dasgupta","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2023.101826_bib22","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1007\/s00259-017-3639-y","article-title":"18F-FDG PET reveals unique features of large vessel inflammation in patients with Takayasu's arteritis","volume":"44","author":"Incerti","year":"2017","journal-title":"Eur J Nucl Med Mol Imag"},{"key":"10.1016\/j.berh.2023.101826_bib23","doi-asserted-by":"crossref","first-page":"4047","DOI":"10.1093\/rheumatology\/keac021","article-title":"Use of 18F-fluorodeoxyglucose positron emission tomography to standardize clinical trial recruitment in Takayasu's arteritis","volume":"61","author":"Quinn","year":"2022","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.berh.2023.101826_bib24","first-page":"74","article-title":"Development of the Takayasu's arteritis integrated disease activity index [abstract]","author":"Marvisi","year":"2022","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.berh.2023.101826_bib25","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1136\/annrheumdis-2017-212649","article-title":"EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice","volume":"77","author":"Dejaco","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2023.101826_bib26","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1002\/art.41774","article-title":"American College of rheumatology\/vasculitis foundation guideline for the management of giant cell arteritis and Takayasu arteritis","volume":"73","author":"Maz","year":"2021","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.berh.2023.101826_bib27","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/RHU.0000000000001801","article-title":"18F-FDG PET\/CT in late acquisition identifies sites of active disease in treated Takayasu arteritis","volume":"28","author":"de Souza Santos","year":"2022","journal-title":"J\u00a0Clin Rheumatol"},{"key":"10.1016\/j.berh.2023.101826_bib28","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.jacc.2022.10.034","article-title":"Somatostatin receptor PET\/MR imaging of inflammation in patients with large vessel vasculitis and atherosclerosis","volume":"81","author":"\u0106orovi\u0107","year":"2023","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.berh.2023.101826_bib29","doi-asserted-by":"crossref","first-page":"296","DOI":"10.2967\/jnumed.120.256271","article-title":"Fapi Pet\/ct: will it end the hegemony of (18)F-FDG in oncology?","volume":"62","author":"Hicks","year":"2021","journal-title":"J\u00a0Nucl Med"},{"issue":"Suppl","key":"10.1016\/j.berh.2023.101826_bib30","doi-asserted-by":"crossref","first-page":"S99","DOI":"10.1016\/S0167-5273(96)88778-X","article-title":"Takayasu arteritis: lessons from the American national Institutes of Health experience","volume":"54","author":"Hoffman","year":"1996","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.berh.2023.101826_bib31","first-page":"S73","article-title":"Plasma pentraxin-3 levels in patients with Takayasu's arteritis during routine follow-up","volume":"34","author":"Alibaz-Oner","year":"2016","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.berh.2023.101826_bib32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0245612","article-title":"Pentraxin 3 is more accurate than C-reactive protein for Takayasu arteritis activity assessment: a systematic review and meta-analysis","volume":"16","author":"Wen","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.berh.2023.101826_bib33","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1186\/s13075-021-02636-2","article-title":"Using the co-expression network of T cell-activation-related genes to assess the disease activity in Takayasu's arteritis patients","volume":"23","author":"Tian","year":"2021","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.berh.2023.101826_bib34","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.646516","article-title":"Potential role of macrophage phenotypes and CCL2 in the pathogenesis of Takayasu arteritis","volume":"12","author":"Kong","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.berh.2023.101826_bib35","article-title":"Enhanced liver fibrosis score as a biomarker for vascular damage assessment in patients with Takayasu arteritis-A pilot study","volume":"8","author":"Stojanovic","year":"2021","journal-title":"J\u00a0Cardiovasc Dev Dis"},{"key":"10.1016\/j.berh.2023.101826_bib36","doi-asserted-by":"crossref","first-page":"Si14","DOI":"10.1093\/rheumatology\/keab487","article-title":"A\u00a0novel model to assess disease activity in Takayasu arteritis based on 18F-FDG-PET\/CT: a Chinese cohort study","volume":"61","author":"Ma","year":"2022","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.berh.2023.101826_bib37","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1007\/s00296-021-04958-5","article-title":"Corticosteroid monotherapy for the management of Takayasu arteritis-a systematic review and meta-analysis","volume":"41","author":"Misra","year":"2021","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.berh.2023.101826_bib38","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.semarthrit.2017.09.014","article-title":"Long-term outcome of 251 patients with Takayasu arteritis on combination immunosuppressant therapy: single centre experience from a large tertiary care teaching hospital in Southern India","volume":"47","author":"Goel","year":"2018","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.berh.2023.101826_bib39","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.autrev.2016.12.009","article-title":"A\u00a0scoping review of the use of non-biologic disease modifying anti-rheumatic drugs in the management of large vessel vasculitis","volume":"16","author":"Misra","year":"2017","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.berh.2023.101826_bib40","doi-asserted-by":"crossref","first-page":"4391","DOI":"10.1007\/s10067-021-05743-2","article-title":"Disease-modifying anti-rheumatic drugs for the management of Takayasu arteritis\u2014a systematic review and meta-analysis","volume":"40","author":"Misra","year":"2021","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.berh.2023.101826_bib41","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1136\/annrheumdis-2017-211878","article-title":"Efficacy and safety of tocilizumab in patients with refractory Takayasu arteritis: results from a randomised, double-blind, placebo-controlled, phase 3 trial in Japan (the TAKT study)","volume":"77","author":"Nakaoka","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2023.101826_bib42","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1093\/rheumatology\/kez630","article-title":"Long-term efficacy and safety of tocilizumab in refractory Takayasu arteritis: final results of the randomized controlled phase 3 TAKT study","volume":"59","author":"Nakaoka","year":"2020","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.berh.2023.101826_bib43","doi-asserted-by":"crossref","first-page":"2360","DOI":"10.1093\/rheumatology\/keab684","article-title":"Vascular imaging of patients with refractory Takayasu arteritis treated with tocilizumab: post hoc analysis of a randomized controlled trial","volume":"61","author":"Nakaoka","year":"2022","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.berh.2023.101826_bib44","article-title":"Clinical and angiographic outcomes of Mycophenolate versus Methotrexate in South Asian patients of Takayasu arteritis: results from an open-label, randomised controlled trial","author":"Padiyar","year":"2022","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.berh.2023.101826_bib45","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1136\/annrheumdis-2021-220832","article-title":"Treatment efficacy and safety of tofacitinib versus methotrexate in Takayasu arteritis: a prospective observational study","volume":"81","author":"Kong","year":"2022","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2023.101826_bib46","doi-asserted-by":"crossref","DOI":"10.1093\/rheumatology\/keac149","article-title":"Treatment of childhood-onset Takayasu arteritis: switching between anti-TNF and anti-IL-6 agents","author":"Sener","year":"2022","journal-title":"Rheumatology"},{"key":"10.1016\/j.berh.2023.101826_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.semarthrit.2022.152018","article-title":"Efficacy and safety of tofacitinib versus leflunomide with glucocorticoids treatment in Takayasu arteritis: a prospective study","volume":"55","author":"Wang","year":"2022","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.berh.2023.101826_bib48","doi-asserted-by":"crossref","DOI":"10.1002\/art.42496","article-title":"Comparative efficacy of secukinumab versus tumor necrosis factor inhibitors for the treatment of Takayasu's arteritis","author":"Tian","year":"2023","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.berh.2023.101826_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2023.103275","article-title":"The effectiveness of tocilizumab and its comparison with tumor necrosis factor alpha inhibitors for Takayasu Arteritis: a systematic review and meta-analysis","volume":"22","author":"Misra","year":"2023","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.berh.2023.101826_bib50","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s10067-021-05973-4","article-title":"A\u00a0systematic review of clinical and preclinical evidences for Janus kinase inhibitors in large vessel vasculitis","volume":"41","author":"Rathore","year":"2022","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.berh.2023.101826_bib51","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.2147\/JIR.S355881","article-title":"Novel Th17 lymphocyte populations, Th17.1 and PD1+Th17, are increased in Takayasu arteritis, and both Th17 and Th17.1 sub-populations associate with active disease","volume":"15","author":"Singh","year":"2022","journal-title":"J\u00a0Inflamm Res"},{"key":"10.1016\/j.berh.2023.101826_bib52","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1002\/art.41084","article-title":"Targeting mechanistic target of rapamycin complex 1 restricts proinflammatory T cell differentiation and ameliorates Takayasu arteritis","volume":"72","author":"Zhang","year":"2020","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.berh.2023.101826_bib53","doi-asserted-by":"crossref","first-page":"739","DOI":"10.2169\/internalmedicine.51.6344","article-title":"A\u00a0case of Takayasu arteritis with repeated coronary artery restenosis after drug-eluting stent implantation successfully treated with a combination of steroids","volume":"51","author":"Yokota","year":"2012","journal-title":"Intern Med"},{"key":"10.1016\/j.berh.2023.101826_bib54","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-93416-0","article-title":"Prevalence of cardiovascular risk factors, the use of statins and of aspirin in Takayasu Arteritis","volume":"11","author":"Laurent","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.berh.2023.101826_bib55","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ijcard.2019.02.046","article-title":"Statins reduce relapse rate in Takayasu arteritis","volume":"287","author":"Kwon","year":"2019","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.berh.2023.101826_bib56","article-title":"Takayasu arteritis: criteria for surgical intervention should not be ignored","volume":"2013","author":"Perera","year":"2013","journal-title":"Int J Vasc Med"},{"key":"10.1016\/j.berh.2023.101826_bib57","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.ejvs.2018.02.030","article-title":"Endovascular versus open surgical intervention in patients with Takayasu's arteritis: a meta-analysis","volume":"55","author":"Jung","year":"2018","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.berh.2023.101826_bib58","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.rdc.2007.09.002","article-title":"Vasculitis: a collection of pearls and myths","volume":"33","author":"Stone","year":"2007","journal-title":"Rheum Dis Clin N Am"},{"key":"10.1016\/j.berh.2023.101826_bib59","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1007\/s00296-017-3656-y","article-title":"Vascular surgery: the main risk factor for mortality in 146 Takayasu arteritis patients","volume":"37","author":"Rosa Neto","year":"2017","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.berh.2023.101826_bib60","doi-asserted-by":"crossref","first-page":"3262","DOI":"10.1002\/art.39335","article-title":"Takayasu arteritis and pregnancy","volume":"67","author":"Comarmond","year":"2015","journal-title":"Arthritis Rheumatol"}],"container-title":["Best Practice & Research Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521694223000128?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521694223000128?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T17:24:22Z","timestamp":1761499462000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521694223000128"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":60,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["S1521694223000128"],"URL":"https:\/\/doi.org\/10.1016\/j.berh.2023.101826","relation":{},"ISSN":["1521-6942"],"issn-type":[{"value":"1521-6942","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management of Takayasu arteritis","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Rheumatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.berh.2023.101826","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101826"}}